Skip to content

Capital Cell

Capital Cell is Europe's first dedicated equity crowdfunding platform for biotechnology and life sciences, based in Barcelona. It connects private investors with early-stage biotech startups, emphasizing expert vetting of investment opportunities.

Founded
2015
Recorded stages
Seed
Focus sectors
Biotech, Healthcare
Recorded regions
Europe, United Kingdom

Online destinations

Find Capital Cell online

Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.

Official links

Pages the organization runs itself.

Overview

Founded in 2015 by CEO Daniel Oliver, Capital Cell is an equity crowdfunding platform that specializes in biotechnology and life sciences. Based in Barcelona, Spain, it aims to democratize access to high-impact investments in the life sciences sector. The platform connects private investors with early-stage biotech and healthtech startups, utilizing a proprietary 'BioExpert Network' of over 800 opinion leaders and biomedical experts to vet projects before they are listed for investment. This unique approach differentiates Capital Cell from traditional crowdfunding platforms, allowing individuals to contribute to advancements in human health while providing startups with both capital and expert validation.

Focus

Capital Cell focuses on investing in biotechnology and life sciences companies through equity crowdfunding. The platform enables investors to participate in funding rounds for startups in these sectors, emphasizing a rigorous vetting process through its BioExpert Network of over 800 opinion leaders and biomedical experts.

Support

Capital Cell adds value to its portfolio companies by providing access to a network of biomedical experts who offer scientific due diligence, enhancing the credibility of the startups. Additionally, the platform democratizes investment opportunities, allowing startups to raise capital from a diverse pool of investors.

Questions

What are Capital Cell's investment criteria?

Capital Cell invests in early-stage biotechnology and life sciences companies, focusing on pre-seed, seed, and seed+ rounds. The firm emphasizes a rigorous vetting process through its BioExpert Network, which consists of over 800 biomedical experts who evaluate each investment opportunity.

How can startups apply or pitch to Capital Cell?

Startups interested in raising capital through Capital Cell can apply via their website. The platform has a selective acceptance rate of approximately 3%, ensuring that only the most promising companies are considered for funding.

What makes Capital Cell different from traditional venture capital firms?

Capital Cell operates as an equity crowdfunding platform specifically for biotech and life sciences, allowing individual investors to participate in funding rounds. This model democratizes access to investments that were previously limited to institutional investors, while also providing startups with validation from a network of biomedical experts.

What is the geographic scope of Capital Cell's investments?

Capital Cell primarily invests in European biotech startups, with a strong focus on Spain and an expanding presence in the UK and other European markets. The firm aims to support innovative health solutions across the continent.

What is the typical check size for investments?

While individual campaign check sizes are not specified, Capital Cell allows minimum investments starting at €100, making it accessible to a wide range of investors. The total amount raised varies by company and funding round.

What kind of post-investment involvement does Capital Cell have?

Capital Cell provides access to its BioExpert Network for portfolio companies, offering scientific due diligence and support. This enhances the credibility of the startups and helps them navigate the challenges of growth and development in the biotech sector.

Check your startup’s fit

Check your startup’s fit with Capital Cell

Similar investors

Organizations that do similar work to Capital Cell.

All investors
Ada Ventures logoInvestor

Ada Ventures is a venture capital firm based in London and Bristol, UK, focusing on early-stage technology companies led by diverse founders. They invest in sectors such as climate equity, economic empowerment, and healthy aging.

Octopus Ventures logoInvestor

Octopus Ventures is a London-based venture capital firm that invests in early-stage companies focused on creating positive societal and environmental impacts. They back founders addressing significant global challenges across various sectors.

Catalyst logoInvestor

Fostering innovation and entrepreneurship in Northern Ireland.

SV Health Investors logoInvestor

SV Health Investors is a healthcare-focused venture capital and growth equity firm based in Boston and London. With over 30 years of experience, it specializes in investing across various healthcare sectors, including biotechnology and medtech.

Superscout Pro

Find faster. Show up verified. Keep your deals private.

$99a year, or $12 a month
Get Pro

Is this page right?Reviewed · How the research works

Something's off